The provision of Emergency Hormonal Contraception (EHC) Services

Descriptions

The Emergency Hormonal Contraception (EHC) service is integrated with the national Pharmacy Contraception Service (PCS), allowing pharmacists to prescribe oral hormonal contraception for both new and repeat prescriptions. This service eliminates the need for clients to visit a General Practice (GP) or clinic, streamlining access to contraception. Providers must adhere to national clinical guidelines and safeguarding policies, including the assessment of Fraser competence for young people. Key standards and guidelines include: • FSRH Clinical Guideline: Emergency Contraception (March 2017, amended July 2023) • FSRH Clinical Guideline: Contraceptive Choices for Young People (2019) • FSRH Clinical Guideline: Barrier Methods for Contraception and STI Prevention (2015) • NICE Guidance PH51: Contraceptive Services for Under 25s (2014) • UK Medical Eligibility Criteria for Contraceptive Use (UKMEC) By integrating these national frameworks with local priorities, the EHC service aims to address health inequalities and empower residents to make informed decisions about their sexual and reproductive health The Provider is responsible for delivering Emergency Hormonal Contraception (EHC) services in line with national guidelines and safeguarding protocols. The Provider is responsible for ensuring that the accredited pharmacist: 1. Assesses Client Needs: • Confirms the client's eligibility for Emergency Hormonal Contraception (EHC) under the Patient Group Direction (PGD). • Conducts a Fraser competency assessment for clients under 16 to ensure they can give informed consent. 2. Provides Emergency Contraception Options: Discusses the full range of emergency contraception options, Supplies Levonorgestrel or Ulipristal Acetate under PGD, ensuring EllaOne is used as the first-line option where protocols allow, but can also include: • Emergency IUD (Copper Coil): Recommended as the most effective option (>99% effectiveness). • Levonorgestrel-based emergency contraception (Levonelle 1500). • Ulipristal Acetate-based emergency contraception (EllaOne). 3. Discusses the Effectiveness of Emergency Contraception: • Covers the benefits, risks, and possible side effects of each emergency contraception option. • Refers or signposts clients to additional services, particularly those at high risk of pregnancy for whom an IUD may be the most effective option. 4. Informs Clients about IUD Effectiveness: • Clearly communicates that an IUD is the most effective method of emergency contraception. 5. Manages Unsuitable Cases: • Advises clients who are unsuitable for EHC or have exceeded the timeframes for Levonorgestrel (72-96 hours) or Ulipristal Acetate (120 hours). To express your interest, kindly complete the Expression of Interest form by using the EOI link attached to this notice, and please see attached service specification and contract attached.